IQ motif-containing GTPase Activating Protein 1 (IQGAP1) is a ubiquitously expressed scaffolding protein that integrates signaling from multiple cellular processes including motility, adhesion, and proliferation. Here, we show that IQGAP1 is induced in the liver upon fasting and can also regulate β-oxidation and ketone body synthesis. Utilizing ketogenic diet and pharmacologic activation we identified that hepatic PPARα activity is compromised in Iqgap1 -/-mice. Our data show that IQGAP1 interacts with the mechanistic target of rapamycin (mTOR) and IQGAP1 deletion results in enhanced mTOR complex 1 (mTORC1) activation. Conversely, ectopic expression of IQGAP1 in Iqgap1 -/-mice was sufficient to suppress mTORC1 signaling.
Introduction
The IQ motif-containing GTPase Activating Protein (IQGAP) family of multi-domain scaffolding proteins includes three members, of which IQGAP1 is the only ubiquitously expressed isoform (1) (2) (3) (4) (5) . IQGAP1 interacts with several binding partners and integrates signals that control diverse cellular processes such as cell-cell adhesion via E-Cadherin (6), cell motility via Cdc42 and Rac1 (7), cell proliferation via the Ras/MAP kinase pathway (8), and membrane receptor signaling via EGF receptor (9). More recently, its role in scaffolding PI-3K/ AKT signaling and subsequent glucose homeostasis has been identified (10, 11). Because IQGAP1 regulates several energy-requiring cellular processes, we hypothesized that IQGAP1 may also coordinate the response to changes in metabolic state.
The liver is a central organ responsible for nutrient metabolism. In the fed state, the liver responds to high insulin levels by promoting de novo lipogenesis to store excess calories in adipose depots (12). On the other hand, in the fasted state, the liver breaks down fatty acids to synthesize ketone bodies, which are an effective alternate fuel source. Ketogenesis is crucial to maintain energy levels during fasting. It can also be induced nutritionally with a lowcarbohydrate, low protein, high-fat diet known as the ketogenic diet (KD). This process is largely regulated transcriptionally by the nuclear receptor PPARɑ (13) (14) (15) (16) (17) (18) .
To characterize the significance of hepatic IQGAP1 induction in fasting, we carefully examined the fasting response in Iqgap1 -/-mice. Upon a 24-hour fast, both WT and Iqgap1 -/-mice (31) lost comparable amount of body weight (figure S1B) and liver weight (figure S1C). As expected, serum glucose levels decreased with fasting, but this decrease was exaggerated in
Iqgap1
-/-mice since these mice were hyperglycemic in the fed state (figure S1D) and exhibited a trend towards insulin resistance (figure S1E). This is in line with recently published data that showed loss of IQGAP1 protein results in poor glucose tolerance (10). However, the observed reduction in fasting glucose is not due to lack of gluconeogenic response in the Iqgap1 -/-livers ( Figure S1F ).
Next, we analyzed the effect of IQGAP1 deletion on lipid metabolism. Fasting increased serum non-esterified fatty acids (NEFAs) and modestly reduced serum triglyceride levels in WT animals (figure 1C-D). Even though fasting levels of serum triglyceride and NEFA were significantly lower in Iqgap1 -/-mice, the fold-changes in these metabolites were comparable between the two groups. This is because, compared to WT, the average serum NEFA and triglyceride levels were lower in Iqgap1 -/-mice even in the fed state. To ensure this was not due to poor fat mobilization, we tested the expression of the three main lipases (Hsl, Lpl, and Atgl) in adipose tissue and found no difference between WT and Iqgap1 -/-( Figure S1G ). The Iqgap1 -/-mice lost on average 8% of their visceral adipose by weight upon fasting while the WT mice lost 5%, indicating that lipolysis defects do not contribute to the observed changes in circulating free fatty acid levels ( Figure S1H ). Furthermore, histological analysis did not reveal any overt difference between WT and Iqgap1 -/-livers, which accumulated triglycerides to a similar extent upon fasting (figure 1C figure S2A ) and showed similar expression of KD-responsive genes (figure S2B) confirming that the metabolic defect is specific to the liver.
To understand why more fat accumulated in Iqgap1 -/-livers, we examined the hepatic expression of genes controlling fatty acid breakdown and ketogenesis. We found that Fgf21
(figure 2E), Carnitine palmitatoyltransferase 1A (Cpt1a), β-oxidation genes Enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase (Ehhadh), Acadm, Hadha, and ketogenic genes hydroxymethylglutaryl-CoA synthase 2 (Hmgcs2) and 3-hydroxybutyrate dehydrogenase (Bdh1), were all significantly down regulated (figure 2F), resulting in lower circulating levels of ketone bodies ( Figure 2G ) in Iqgap1 -/-animals. These results clearly indicate that IQGAP1 is required for long-term adaptation to nutritional ketosis.
Loss of IQGAP1 deregulates PPARɑ activation subsequent to mTORC1 activation.
We next examined whether deletion of IQGAP1 affects the activation of the nuclear receptor PPARɑ, a critical transcriptional regulator of the fasting and ketogenic response (14, 16 showed significantly reduced induction in Iqgap1 -/-mice while Hadha showed a similar but insignificant trend ( figure 3A ). However, Fgf21 showed comparable fold induction (figure 3A).
Serum ketone bodies also reflected a lower range in Iqgap1 -/-mice (figure S3B). We confirmed the cell autonomous function of IQGAP1 using primary hepatocytes from WT and Iqgap1 -/-mice.
When we challenged the primary hepatocytes with WY, only the WT cells were able to increase Fgf21 transcript levels ( figure S3D ). These results reveal specific defects in fatty acid β-oxidation and ketone synthesis in Iqgap1 -/-hepatocytes, indicating the requirement of IQGAP1 for these metabolic processes.
It has been previously shown that the major nutrient sensor mTORC1 can suppress transcription of ketogenic PPARɑ targets (21) . Therefore, we assessed mTORC1 activity in the liver by measuring phosphorylation of two bona fide markers S6 ribosomal protein and 4E-BP1.
S6 phosphorylation at S240,244 and S235,236 sites along with phosphorylation of 4E-BP1 was increased in Iqgap1 -/-livers compared to WT upon WY-treatment (figure 3B). We then examined if the observed elevated mTORC1 activity was unique to WY treatment or was intrinsic in the
Iqgap1
-/-livers. To address this, we analyzed fasted and re-fed WT and Iqgap1 -/-mouse livers and found that compared to WT, Iqgap1 -/-mice exhibit a robust 2-fold increase in hepatic mTORC1 activity upon re-feeding ( figure 3C ). To further confirm increased mTORC1 activation, we analyzed Srebp1c and Fasn expression levels, which are suppressed in liver-specific TSC1 knockouts that have chronic mTORC1 activation (33). We found robust down regulation of these two genes in Iqgap1 -/-livers ( figure 3D ). Additionally, we found that phosphorylation of S6 was higher in cultured primary hepatocytes that lacked IQGAP1 ( figure S3D ), further confirming a cell autonomous role for IQGAP1. To determine if IQGAP1 could regulate mTORC1 through direct interaction, we expressed FLAG-tagged IQGAP1 in HepG2 cells and pulled down IQGAP1-interacting proteins using an anti-FLAG antibody. We found increased pull down of mTOR in cells expressing FLAG-IQGAP1 ( figure S3D ) implying interaction of IQGAP1 with mTOR. Based on these data we infer that IQGAP1 levels are important in maintaining hepatic mTORC1 activity.
Hepatic fatty acid oxidation defect in Iqgap1 -/-mice can be alleviated by either re-
expressing IQGAP1 or inhibiting mTORC1
We re-expressed IQGAP1 specifically in the livers of Iqgap1 -/-mice using an adenoviral system to determine whether this is sufficient for inducing a normal metabolic response.
IQGAP1 over-expression resulted in reduction of mTORC1 activity (figure 4A) as well as induction of the fatty acid oxidation genes (figure 4B). Similarly, overexpressing IQGAP1 in the HepG2 cell line reduced S6 phosphorylation ( figure S4A ). These data reveal that IQGAP1 levels are necessary to maintain mTORC1 signaling. Finally, we tested if inhibiting mTORC1 activation with rapamycin can reverse any of the ketogenic defects observed in Iqgap1 -/-mice. We first ensured that loss of IQGAP1 did not affect mTORC1 inhibition by rapamycin both in vivo ( figure   S4B ) and in vitro ( figure S4C ). We found that Iqgap1 -/-mice treated with rapamycin were able to increase a subset of PPARɑ target genes including Hmgcs2, Fasn, and Acadm to even higher levels than that of the WT ( figure 4C ). However, Ppara and Cpt1a levels remained blunted in
Iqgap1
-/-mice and was recapitulated in primary Iqgap1 -/-hepatocytes ( figure 4D, figure S4C ).
Overall, these results suggest that hepatic IQGAP1 regulates ketogenesis in an mTORC1-dependent and -independent manner (figure 4E).
Deletion of murine IQGAP1 results in increased mTOR activation and blunted ketogenic response
Discussion
IQ motif-containing GTPase Activating Protein 1 (IQGAP1) is a cytoskeleton-associated scaffolding protein that functions in numerous multi-protein complexes and can interact with over 90 proteins. These include the MAP kinase pathway (34), PI3 kinase and AKT (3, 11), calmodulin (35), and FoxO1 (36). To investigate the role for IQGAP1 in coordinating metabolic signaling, we analyzed WT and Iqgap1 -/-mice under different nutritional conditions. We found that IQGAP1 expression was increased upon fasting and Iqgap1 -/-animals showed reduced fatty acid oxidation in the liver. However, increases in gluconeogenic genes were maintained.
This could be attributed to intact expression of Pgc1a levels, a key regulator of gluconeogenesis (37), in the livers of Iqgap1 -/-mice.
Typically, prolonged fasting leads to ketone body synthesis, which serves an effective alternate fuel source. In particular, we found that IQGAP1 was required to maintain persistent ketogenesis. For instance, when we mimicked this metabolic state using a ketogenic diet (KD) for 4 weeks (38, 39), the Iqgap1 -/-mice showed a poor ability to break down fat and synthesize ketone bodies compared to WT mice. We mapped this to PPARɑ signaling defect in Iqgap1 -/-mice. Importantly, Iqgap1 -/-mice mimic Ppara -/-mice, with both exhibiting elevated hepatic triglycerides, reduced expression of β-oxidation genes, and lower serum FGF21 and ketone body levels during prolonged ketosis (16) . Similarly, 24-hour fasting resulted in reduced expression of some genes involved in fatty acid oxidation in Iqgap1 -/-mice relative to WT mice.
However, this was not reflected at the serum ketone levels. This is similar to that of the Fgf21 -/-mice, which also show lower ketone body levels when fed KD but do not show changes in ketone levels after 24 hour fast (40, 41). Thus, IQGAP1 may be crucial during long-term fasting specifically.
We confirmed that PPARa downstream signal is dampened when IQGAP1 is deleted by treating mice with the PPARɑ agonist Wy-14,643 (WY). Interestingly, we found that induction of a subset of PPARa target genes responsible for fatty acid oxidation was specifically reduced in Typically, mTORC1 is the major regulator of cellular energetics, but we have not ruled out the role for mTORC2 in this study.
In conclusion, our findings reveal the importance of IQGAP1 in modulating mTORC1
activity and subsequent control of nutritional response in the liver. In addition, PPARa activity, specifically fatty acid oxidation and ketogenesis, is impaired when IQGAP1 is deleted. We therefore postulate that the IQGAP1 scaffold could coordinate multiple facets of long-term ketogenesis.
Materials and Methods

Animal experiments
Wild 
Primary hepatocyte culture
Mouse hepatocytes were isolated using a two-step collagenase perfusion technique (48). Iqgap1 and rtTA plasmids using Mirus TransIT-X2 kit. The next day, the media was replaced with fresh DMEM containing 2 ng/mL dox, and protein was collected 24 hours later.
Serum chemistry
Serum was thawed on ice prior to each metabolite assay. absorbance was read at 570 nm and was adjusted for background reading at 600 nm.
Additionally, Mouse/Rat FGF-21 Quantikine ELISA kit (R&D Systems) was used to measure serum FGF21 levels. Serum glucose was measured using one-touch glucose strips on fresh tail blood.
Glucose tolerance test
Glucose tolerance test (GTT) was performed as previously described (50). Briefly, mice were fasted for 13 hours overnight and administered 2g/kg D-glucose intraperitoneally. Blood glucose concentrations were measured at 0, 15, 30, 60, and 120 min after injection using tail blood.
Hepatic triglyceride assay
Frozen liver tissue (<50 mg) was weighed and homogenized in 1 mL of isopropanol. Samples were centrifuged at 4°C and 10,000 rpm for 15 minutes, and supernatant-containing triglycerides was separated. Triglyceride content was measured using Infinity Triglyceride Liquid Stable Reagent (Fisher Scientific).
Histology
Formalin fixed liver samples were embedded in paraffin wax. Five micron sections were cut and used for hematoxylin and eosin (H&E) staining according to standard methods (51).
Quantitative RT-PCR
Total RNA from frozen whole liver tissue was extracted using TRIzol solution (Invitrogen) according to manufacturer's protocol. RNA quality was determined by A260/280 and bleach RNA gel as previously described (52). RNA (5 µg) was treated with DNase (Promega) and reverse transcribed using random hexamer primer (New England Biosciences) and Maxima
Reverse Transcriptase kit (Thermo Scientific). The cDNA was diluted to 12.5 ng/µL with molecular grade water (Corning) and used for qRT-PCR assays. qRT-PCR was performed on an Eco Real-Time PCR system (Illumina) in triplicate using 50 ng of cDNA per reaction and PerfeCTa SYBR Green FastMix (Quanta). All assays were run with an initial activation step for 10 min. at 95 °C, followed by 40 cycles of 95 °C for 10 sec and 60 °C for 30 sec. Primer sequences are described in Table S1 . Gapdh. β-Actin, and 36b4 were used as housekeeping genes.
Western blot analysis
Protein was extracted from approximately 50 mg of frozen liver tissue. RIPA buffer (25mM Tris pH 7, 150mM NaCl, 0.5% sodium deoxycholate, protease inhibitor (Pierce Protease Inhibitor Deletion of murine IQGAP1 results in increased mTOR activation and blunted ketogenic response Mini Tablets, EDTA Free; ThermoFisher Scientific), phosphatase inhibitor (Phosphatase Inhibitor Cocktail 3; Sigma Aldrich), and 1% Triton X-100) was added to each liver sample, which was homogenized by adding 8-10 1mm beads and bullet blending for 3 x 1 minute with 1 minute on ice in between. Samples were sonicated until non-viscous. Protein concentration was measured by BCA assay (Pierce BCA Protein Assay Kit, Thermo Fisher Scientific). For western blot, 10-50 µg of total protein was loaded onto 8-12% SDS-PAGE gels. After transfer, the membrane was incubated with antibodies described in Table S2 .
Co-Immunoprecipitation
HepG2 cells were transfected with dox-inducible FLAG-IQGAP1 and were treated with dox or vehicle for 24 hours. After induction, approximately 10 7 cells were lysed in lysis buffer (50 mM Tris pH7.8, 150 mM NaCl, 30mM EDTA, 0.5% Triton X100). The lysate was then split and equal amounts were immunoprecipitated with a FLAG antibody overnight, washed, and resolved on an 8% SDS-PAGE gel. After transfer, blots were probed with antibodies for mTOR.
Statistical Analysis
Data are expressed as mean ± SD. Student's unpaired two-tailed t-test was used to compare two groups. A * indicates a statistically significant difference between the treatment group and its respective genotype control unless the groups are otherwise indicated. Significance is defined as p < 0.05, with * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001. Outliers were determined by Grubbs' test and removed from analysis. 
